Jerome D. S.
- Country
- France
- Department
- Neurologie
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized Double-Blind Study of Orelabrutinib for Primary Progressive Multiple Sclerosis in Patients With PPMS
- TRIO: A prospective randomized Trial of non-inferiority comparing RItuximab versus Ocrelizumab in relapsing-remitting multiple sclerosis.
Data & Insights
Has run more than one trial at 310 of 507 partner sites.
Specializations
Multiple Sclerosis Research
This investigator demonstrates extensive involvement in the field of multiple sclerosis (MS), with particular focus on both relapsing and progressive forms of the disease. Their research encompasses pediatric MS treatment and long-term therapeutic approaches.
- Relapsing-Remitting Multiple Sclerosis
- Progressive Multiple Sclerosis
- Pediatric MS Management
Their work includes evaluation of novel therapeutic agents and comparative treatment strategies.
Autoimmune Neurological Conditions
The investigator specializes in treating various autoimmune neurological disorders, with particular emphasis on Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
- MOGAD Treatment Development
- CIDP Management
- Autoimmune Neuropathies
Their research includes investigation of innovative therapeutic approaches for these conditions.
Specialized Neurological Disorders
The investigator's expertise extends to rare and complex neurological conditions, including Sjögren's syndrome-related neuropathies and paraneoplastic sensory neuropathies.
- Paraneoplastic Syndromes
- Peripheral Neuropathies
- Immunotherapy Applications
Their work involves exploring immunological treatments for these specialized conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.